QT alterations in psychopharmacology: proven candidates and suspects.
about
QTc prolongation by psychotropic drugs and the risk of Torsade de PointesCardiovascular considerations in antidepressant therapy: an evidence-based reviewElectrophysiological study of V535M hERG mutation of LQT2.Sudden death of cardiac origin and psychotropic drugsNorepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome.Evaluation of Changes in Citalopram Prescribing Patterns Following a US Food and Drug Administration Alert: A Retrospective Cohort Study.Electrocardiograms changes in children with functional gastrointestinal disorders on low dose amitriptyline.Pharmacological treatment for generalized anxiety disorder in adults: an update.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicityTuning HERG out: antitarget QSAR models for drug developmentEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Safety and tolerability of antipsychotic polypharmacy.Pred-hERG: A Novel web-Accessible Computational Tool for Predicting Cardiac Toxicity.Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with SchizophreniaAntidepressants and QTc prolongation.New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania.Hypothermic overdose, not all bad?Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery.Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cellsGender differences in antipsychotic prescribing.Ziprasidone for maintenance treatment of bipolar I disorder in adults.Probable quetiapine-mediated prolongation of the QT interval.Treatment-emergent adverse events associated with atypical antipsychotics.The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis.Receptor mechanisms of antipsychotic drug action in bipolar disorder - focus on asenapineEfficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials.Many-to-one comparisons after safety selection in multi-arm clinical trials.Molecular analysis of potassium ion channel genes in sudden death cases among patients administered psychotropic drug therapy: are polymorphisms in LQT genes a potential risk factor?[Gender differences in acute and chronic pain conditions. Implications for diagnosis and therapy].Fatal arrhythmogenic right ventricular cardiomyopathy in 2 related subadult chimpanzees (Pan troglodytes).The toxicology and comorbidities of fatal cases involving quetiapine.Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.Follow-Up (Measurement) of Corrected QT Interval in Adult Patients before and after Lung Transplantation.Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.The effects of diltiazem and metoprolol in QTc prolongation due to amitriptyline intoxication.Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study.[Gender aspects in anesthesia : modified approach in research and treatment?].
P2860
Q27015763-D0BCAAE7-2182-4DCC-AAE7-BADDA71E5938Q27021843-ECCA37D4-1F86-4AAD-9654-557ED4D8D7E3Q33160777-583D2590-C1C0-43C2-9568-6256F63E3D43Q33161295-6902790F-30DB-41CD-89A7-509120AF1210Q33162642-AA7F1139-BDD5-4021-AA7E-C2D425FB785FQ33165968-25C8B23F-D0E0-4141-870D-1097337C2B03Q34093866-2367CD1E-214A-47D0-92CC-53969647F553Q34484276-B90C240C-407D-460E-8059-6BC3357A8079Q34623350-B2F17B11-655B-4055-9DAC-56399E1C45C6Q35008383-C2DDF832-D10B-4358-ABC3-4E0090660978Q35164442-30AE4122-2857-48A4-9E80-5FAEEC16CCC7Q35754726-5B425B86-6B6D-4A9F-BE1C-D48E7FA87541Q36062421-5AC7EF06-989A-48EB-8260-4FA4C667317BQ36095155-254F459C-D29D-46F8-9A77-6E6743D6FFF9Q36169130-5CA58DDD-21B6-45D9-AB97-DBD55F13E57FQ36636333-A27E1D83-BA36-41C6-A439-8117C64E834CQ36929705-85CEEE04-9D8A-4486-B59A-D4CB0AEC5D6AQ37102680-A3E045A0-39E2-4D52-828F-E07EE2C88403Q37401584-F500D4F2-7E3E-4629-88A1-A4FF8EF41BA0Q37729074-5B3F8D10-A224-4E03-A270-88851793E7CDQ37806755-0D1282EC-D8CD-4846-B208-CD86D155B797Q37850820-ED0CD3BB-90BE-4B9E-9627-7D771269CA84Q37918068-E202BA0D-5838-4634-A480-3347FA20AF70Q37981271-AE70FACC-1C60-465D-B5CB-49A2DAC33C31Q38045833-5C601078-01E3-4E13-83F0-375D2402625FQ38132163-447221D1-5105-4EA3-8F9B-93C77E769840Q38304559-158189D9-C239-4CD0-94D6-971A5835374EQ38708697-21E69433-6856-4525-A124-2327A54670F5Q44028648-BF65C879-7425-49A6-9C60-1EAEEB958023Q44391988-CABA299E-FBAC-446D-AA76-0E112FED7D95Q45325563-B333EED7-1CD6-4FAD-BBE9-2E1ECB8953CEQ46114930-594BA2BA-9A4E-496C-BBD5-727AB98AE63CQ46455559-70871C40-8E86-4944-BE82-71A6A073CDACQ47132054-5EA3737C-18F8-4AE7-A941-A43D3AAE7698Q47569717-881A13F4-A244-451D-9C48-827C8492CC8AQ47742216-301A4322-D129-4878-9176-B852DDFDC331Q49645667-7931FEBF-98DD-462A-A330-DE582FD8FA6BQ51300430-789E2EE1-3631-45E4-99CF-763E6539C206Q51382080-0D640FE0-553A-449D-AC39-A4A74410C7DDQ53098680-6977ED5F-1C6E-4A45-9CCA-19BF71C4BC29
P2860
QT alterations in psychopharmacology: proven candidates and suspects.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
QT alterations in psychopharmacology: proven candidates and suspects.
@ast
QT alterations in psychopharmacology: proven candidates and suspects.
@en
QT alterations in psychopharmacology: proven candidates and suspects.
@nl
type
label
QT alterations in psychopharmacology: proven candidates and suspects.
@ast
QT alterations in psychopharmacology: proven candidates and suspects.
@en
QT alterations in psychopharmacology: proven candidates and suspects.
@nl
prefLabel
QT alterations in psychopharmacology: proven candidates and suspects.
@ast
QT alterations in psychopharmacology: proven candidates and suspects.
@en
QT alterations in psychopharmacology: proven candidates and suspects.
@nl
P1433
P1476
QT alterations in psychopharmacology: proven candidates and suspects.
@en
P2093
Jaime Pahissa
Paulino Antonio Alvarez
P304
P356
10.2174/157488610789869265
P577
2010-01-01T00:00:00Z